Sunshine Heart Inc (NASDAQ:CHFS) hit a new 52-week high and low on Monday . The company traded as low as $2.50 and last traded at $2.71, with a volume of 75434 shares trading hands. The stock had previously closed at $2.79.
Separately, Zacks Investment Research upgraded shares of Sunshine Heart from a “hold” rating to a “buy” rating and set a $4.25 price objective on the stock in a research note on Wednesday, December 6th.
The company has a market cap of $10.60, a price-to-earnings ratio of -0.07 and a beta of 2.25.
COPYRIGHT VIOLATION NOTICE: “Sunshine Heart (CHFS) Sets New 52-Week High and Low at $2.50” was first published by Enterprise Leader and is owned by of Enterprise Leader. If you are reading this news story on another domain, it was copied illegally and republished in violation of US and international copyright law. The legal version of this news story can be accessed at https://theenterpriseleader.com/2018/04/02/sunshine-heart-chfs-sets-new-52-week-high-and-low-at-2-50.html.
About Sunshine Heart
CHF Solutions, Inc, an early-stage medical device company, develops cardiac and coronary disease products primarily in the United States. It focused on commercializing the Aquadex FlexFlow system, which is indicated for temporary ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy, and extended ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization.
Receive News & Ratings for Sunshine Heart Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sunshine Heart and related companies with MarketBeat.com's FREE daily email newsletter.